Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $10.44 Analyst target: $6.00 Upside: -42.53%
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and internationally. The company is headquartered in Los Angeles, California.
See the full interactive analysis & chart →Informational only — not investment advice.